bool(false)

Health and Pharmaceuticals Committee

Formed in 2002
Position Paper 2019

Chairperson

Yury Litvishchenko Chiesi Pharmaceuticals LLC

Deputy Chairperson(s)

Ivan Glushkov Stada CIS

Coordinator

Olga Silnitskaya olga.silnitskaya@aebrus.ru

Upcoming events

11.12.2019 10:00 Heath and Pharmaceuticals Committee meeting | AEB Conference room

If you are AEB member, Log in to register for the committee meeting or contact the Committee coordinator

Objectives
  • To coordinate and protect the interests of AEB Member Companies working in health and pharmaceuticals.
Action Plan
  • To coordinate activities with the Association of International Pharmaceutical Manufacturers (AIPM)
  • To lobby for improvement in licensing and certification procedures
  • Meetings with officials from the Ministry of Health and the State Customs Committee
  • To focus on the following issues: to impact trends in the future development following recent changes in certification procedures and the implementation of the new Customs Code
  • To address intellectual property issues
  • To combat counterfeiting
  • To address brand protection issues
  • To address unfair competition
Committee news
08.10.2019
AEB Health and Pharmaceuticals Committee met with the representatives of the Federal Antimonopoly Service (FAS)
30.05.2019
AEB and GfK presented the results of the 12th Annual Survey “Strategies and Prospects for European companies in Russia”
29.01.2019
AEB - FAS meeting on pharma issues
25.09.2018
Round table "Big Pharma’s Anticompetitive Practices: BRICKs+ Competition Authorities’ Response"
22.03.2017
10th meeting of the WG for Research on the Competition Issues in the Pharmaceutical Sector
10.06.2015
Best health and safety practices in the pharmaceutical industry
26.05.2015
AEB presents the 1st draft of the Code of Conduct for pharmaceutical producers
10.04.2015
Round Table "Localisation of Pharmaceutical Production in Russia: Yesterday, Today and Tomorrow"
13.03.2015
The Pharmaceutical Market: Creation of Fair Play Rules on the Pharmaceutical Markets of the BRICS and CIS countries
29.01.2014
AEB Health and Pharmaceuticals Committee open event
.comitee-more-button { -moz-box-shadow:inset 0px 1px 0px 0px #ffffff; -webkit-box-shadow:inset 0px 1px 0px 0px #ffffff; box-shadow:inset 0px 1px 0px 0px #ffffff; background:-webkit-gradient( linear, left top, left bottom, color-stop(0.05, #ededed), color-stop(1, #dfdfdf) ); background:-moz-linear-gradient( center top, #ededed 5%, #dfdfdf 100% ); filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#ededed', endColorstr='#dfdfdf'); background-color:#ededed; -webkit-border-top-left-radius:6px; -moz-border-radius-topleft:6px; border-top-left-radius:6px; -webkit-border-top-right-radius:6px; -moz-border-radius-topright:6px; border-top-right-radius:6px; -webkit-border-bottom-right-radius:6px; -moz-border-radius-bottomright:6px; border-bottom-right-radius:6px; -webkit-border-bottom-left-radius:6px; -moz-border-radius-bottomleft:6px; border-bottom-left-radius:6px; text-indent:0; border:1px solid #dcdcdc; display:inline-block; color:#777777; font-family:arial; font-size:15px; font-weight:bold; font-style:normal; height:50px; line-height:50px; width:auto; text-decoration:none; text-align:center; text-shadow:1px 1px 0px #ffffff; } .comitee-more-button:hover { background:-webkit-gradient( linear, left top, left bottom, color-stop(0.05, #dfdfdf), color-stop(1, #ededed) ); background:-moz-linear-gradient( center top, #dfdfdf 5%, #ededed 100% ); filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#dfdfdf', endColorstr='#ededed'); background-color:#dfdfdf; }.comitee-more-button:active { position:relative; top:1px; } Code of Good Practice Recommendations on OTC Drug Advertising


Back to the list